ABACUS 3CP

K111534 · Diatron U.S., Inc. · GKZ · Aug 2, 2012 · Hematology

Device Facts

Record IDK111534
Device NameABACUS 3CP
ApplicantDiatron U.S., Inc.
Product CodeGKZ · Hematology
Decision DateAug 2, 2012
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 864.5220
Device ClassClass 2

Intended Use

The Diatron Abacus 3CP System is a quantitative multi-parameter automated hematology analyzer designed for in-vitro-diagnostic use in clinical laboratories for enumeration of the following parameters: WBC, LYM%, LYM#, MID%, MID#, GRA%, GRA#, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV in K3EDTA anti-coagulated venous whole blood samples. The Diatron Abacus 3CP is indicated for use to identify patients with hematologic parameters within and outside of established reference ranges.

Device Story

Abacus 3CP is a fully automated, bench-top hematology analyzer for clinical laboratories. It processes K3EDTA anticoagulated venous whole blood samples via manual sampling in open or closed vial modes. The device utilizes impedance technology to count cells (WBC, RBC, PLT) passing through small apertures and a photometric method to measure hemoglobin (HGB). Other parameters (LYM, MID, GRA, HCT, MCV, MCH, MCHC, RDW, MPV) are derived or calculated. The system features a color LCD, foil keypad, and optional built-in printer or external USB printer connectivity. It stores 1000 records with histograms. Data can be exported via USB or RS232 serial link. Healthcare providers use the generated reports to assess patient hematologic status against reference ranges, aiding in clinical decision-making regarding blood health.

Clinical Evidence

No clinical data provided. The submission relied on software and system verification and validation testing performed in accordance with the Class II Special Controls Guidance Document for Automated Differential Cell Counters. Risk and hazard analysis were conducted per ISO 14971.

Technological Characteristics

Bench-top automated hematology analyzer. Sensing: Impedance (WBC, RBC, PLT) and Photometric (HGB). Aperture diameters: 100 µm (WBC), 80 µm (RBC/PLT). Connectivity: USB (slave/flash), RS232. User interface: Color LCD, 29-key foil keypad. Software updateable via USB. Sterilization: Not applicable (in-vitro diagnostic).

Indications for Use

Indicated for clinical laboratory use to perform quantitative multi-parameter hematology analysis (WBC, LYM, MID, GRA, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV) on K3EDTA anticoagulated venous whole blood samples to identify patients with hematologic parameters within or outside established reference ranges.

Regulatory Classification

Identification

An automated differential cell counter is a device used to identify one or more of the formed elements of the blood. The device may also have the capability to flag, count, or classify immature or abnormal hematopoietic cells of the blood, bone marrow, or other body fluids. These devices may combine an electronic particle counting method, optical method, or a flow cytometric method utilizing monoclonal CD (cluster designation) markers. The device includes accessory CD markers.

Special Controls

*Classification.* Class II (special controls). The special control for this device is the FDA document entitled “Class II Special Controls Guidance Document: Premarket Notifications for Automated Differential Cell Counters for Immature or Abnormal Blood Cells; Final Guidance for Industry and FDA.”

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K111534 2 2012 AUG ## 510(k) Summary | 510(k) Summary | | |--------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Submitter: | Diatron US Inc.<br>14026 W. 107th Street<br>Lenexa, Kansas 66215-2005 | | Contact<br>Person: | Michael Switzer, Director, Quality Assurance<br>P: 954-790-9550<br>F: 954-827-2644<br>E: mike.switzer@diatron.com | | Date<br>Prepared: | April 27, 2012 | | Trade Name: | Abacus 3CP, Automated Hematology Analyzer | | Classification: | Class II<br>Automated Differential Cell Counter<br>21 CFR §864.5220 | | Product<br>Code: | GKZ | | Predicate<br>Device(s): | The subject device is equivalent to the following device:<br>Abbott CELL-DYN® 1800 (K030513) | | Device<br>Description: | The 'Abacus 3CP' is a fully automated, bench top hematology cell counter with a cap<br>piercing function. It uses the impedance-method for counting cells passing through a<br>small aperture, and measures the hemoglobin content of red blood cells using a<br>photometric method. The analyzer features a color graphical LCD display module and<br>a foil keypad of 29 keys including 6 software buttons, 6 function keys and a START<br>button. The instrument allows printing reports to an external printer (USB port), or can<br>have an optional built-in printer module. Its internal memory is capable of storing 1000<br>records with full histograms, and individual patient data. The QC measurements are<br>stored in a separate database. The software operating the instrument can be updated<br>by using a USB flash memory device. The instrument can be connected to a host<br>computer for uploading records in its memory through a USB SLAVE port (USB B) or<br>serial link (RS232). Archiving records to an USB flash memory device is also possible. | | Indications for<br>Use: | The Diatron Abacus 3CP System is a quantitative multi-parameter automated<br>hematology analyzer designed for in-vitro-diagnostic use in clinical laboratories for<br>enumeration of the following parameters: WBC, LYM%, LYM#, MID%, MID#, GRA%,<br>GRA#, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV in K3EDTA anti-<br>coagulated venous whole blood samples. The Diatron Abacus 3CP is indicated for use<br>to identify patients with hematologic parameters within and outside of established<br>reference ranges. | | Functional<br>and Safety<br>Testing: | To verify that device design met it's functional and performance requirements, a<br>representative sample of the device underwent software and system verification and<br>validation testing, in accordance with Class II Special Controls Guidance Document:<br>Premarket Notifications for Automated Differential Cell Counters for Immature or<br>Abnormal Blood cells. A risk and hazard analysis was performed per ISO 14971. | 1 {1}------------------------------------------------ | Substantial | | Similarities | | | |--------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--| | Equivalence: | Item | Diatron Abacus 3CP | Abbott CELL-DYN 1800 | | | | Indication for Use | The Diatron Abacus 3CP System is a<br>quantitative multi-parameter automated<br>hematology analyzer designed for in-vitro-<br>diagnostic use in clinical laboratories for<br>enumeration of the following parameters:<br>WBC, LYM%, LYM#, MID%, MID#,<br>GRA%, GRA#, RBC, HGB, HCT, MCV,<br>MCH, MCHC, RDW, PLT, MPV in<br>K3EDTA anti-coagulated venous whole<br>blood samples. The Diatron Abacus 3CP<br>is indicated for use to identify patients with<br>hematologic parameters within and<br>outside of established reference ranges. | The CELL-DYN 1800 System is an<br>automated, multiparameter<br>hematology analyzer designed to<br>report sixteen parameters relating<br>to the cells of EDTA-anticoagulated<br>blood. | | | | Number of<br>Parameters | 16 | Same | | | | Methodology | WBC = Impedance<br>LYM = Calculated<br>LYM% = Derived<br>MID = Calculated<br>MID% = Derived<br>GRA = Calculated<br>GRA% = Derived<br>RBC = Impedance<br>HGB = Photometric<br>HCT = Calculated<br>MCV = Derived<br>MCH = Calculated<br>MCHC = Calculated<br>RDW = Derived<br>PLT = Impedance<br>MPV = Derived | Same | | | | Sample Type | K3 EDTA anticoagulated venous whole<br>blood | Same | | | | Sample Container | Open and Closed | Same | | | | Sampling System | Manual | Same | | | | Samples per hour | 60 | Same | | | | Aperture Diameter | WBC 100 µm; RBC/PLT 80 µm | Same | | | | | | | | | | Differences | | | | | | Item<br>Sample Volume | Diatron Abacus 3CP<br>Open Vial Mode – 100 µL<br>Closed Vial Mode – 100 µL | Abbott CELL-DYN 1800<br>Open Vial Mode – 30 µL<br>Closed Vial Mode - 450 µL | | | Performance: | All required software and system verification and validation procedures have been executed<br>and analyzed per FDA recommended standards and the Class II Special Controls<br>Guidance Document: Premarket Notifications for Automated Differential Cell Counters for<br>Immature or Abnormal Blood Cells. All risk and hazard analysis have been performed and<br>documented per ISO 14971 guidelines. All performance and accuracy data and data<br>analysis in this submission support and substantiate equivalence to the selected predicate<br>device (Abbott CELL-DYN® 1800 (K030513)). | | | | | Conclusion: | Diatron considers the Abacus 3CP to be equivalent to the predicate device listed<br>above. This conclusion is based upon the devices' similarities in principles of<br>operation, technology, and indications for use. | | | | | | | | | | {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States of America. The seal features the department's name arranged in a circular pattern around the edge. In the center is a stylized emblem that resembles a bird or abstract human figures, symbolizing health and human services. 10903 New Hampshire Avenue Silver Spring, MD 20993 AUG 0 2 2012 Diatron US Inc. c/o Mr. Michael Switzer Director, Quality Assurance 14026 W. 107th Street Lenexa. KS 66215-2005 Re: k111534 Trade/Device Name: Abacus 3CP Regulation Number: 21 CFR § 864.5220 Regulation Name: Automated differential cell counter Regulatory Class: Class II Product Code: GKZ Dated: July 30, 2012 Received: July 31, 2012 Dear Mr. Switzer: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of {3}------------------------------------------------ Page 2 - Mr. Michael Switzer medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Riena Philip Maria M. Chan, Ph.D. Director Division of Immunology and Hematology Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ## Indications for Use Form 510(k) Number (if known): k111534 Device Name: Abacus 3 CP Indications for Use: The Diatron Abacus 3CP System is a quantitative multi-parameter automated hematology analyzer designed for in-vitro-diagnostic use in clinical laboratories for enumeration of the following parameters: WBC, LYM%, LYM#, MID%, MID#, GRA%, GRA#, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, PLT, MPV in KgEDTA anticoagulated venous whole blood samples. The Diatron Abacus 3CP is indicated for use to identify patients with hematologic parameters within and outside of established reference ranges. Prescription Use X AND/OR (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurregce of CDRH, Office of In Vitro Diagnostic Devices (OIVD) Division Sign off Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety 510(k) K111534
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%